Literature DB >> 7322500

Decision-making in the management of microbial keratitis.

D B Jones.   

Abstract

The successful management of suppurative microbial keratitis requires five steps: (1) make the clinical diagnosis, (2) perform the proper laboratory procedures, (3) initiate antimicrobial therapy, (4) modify the initial therapy, and (5) terminate therapy. The most helpful guidelines to decision-making in these steps are: (1) the clinical impression, (2) severity of keratitis, (3) results of laboratory studies, (4) disease potential of the responsible organism, and (5) effectiveness and toxicity of various antimicrobial agents. Selection of initial antibiotics ideally should be directed by interpretation of the corneal smears. The preferred initial antibiotic for keratitis caused by a Gram-positive coccus is cefazolin; for a Gram-negative rod, gentamicin; and for a filamentous fungi or yeast, natamycin. Broad, antibacterial therapy should be reserved for suspected bacterial keratitis with negative smears or for severe infections with antecedent treatment. Miconazole may be an effective, alternate agent in fungal keratitis. The safety and efficacy of corticosteroids in microbial keratitis have not been established.

Entities:  

Mesh:

Year:  1981        PMID: 7322500     DOI: 10.1016/s0161-6420(81)34943-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

1.  Microbial keratitis: what's the preferred initial therapy? View 1: corneal scraping and combination antibiotic therapy is indicated.

Authors:  R Mills
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Overview: Initial antimicrobial therapy for microbial keratitis.

Authors:  M Daniell
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro.

Authors:  Jiong Wang; Tanja Stachon; Timo Eppig; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-02       Impact factor: 3.117

4.  Strategies for the management of microbial keratitis.

Authors:  B D Allan; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

5.  Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results.

Authors:  M J Bharathi; R Ramakrishnan; R Meenakshi; S Mittal; C Shivakumar; M Srinivasan
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

6.  Orally administered antifungal therapy for experimental keratomycosis.

Authors:  D M O'Day
Journal:  Trans Am Ophthalmol Soc       Date:  1990

7.  Treatment of fungal keratitis by penetrating keratoplasty.

Authors:  L Xie; X Dong; W Shi
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

8.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

9.  Non-viral microbial keratitis in children.

Authors:  Abdullah G Al-Otaibi
Journal:  Saudi J Ophthalmol       Date:  2011-10-13

10.  Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers.

Authors:  H G Bennett; J Hay; C M Kirkness; D V Seal; P Devonshire
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.